The DNA-PKcs/JNK/p53 pathway underlies changes in cell fate decision toward death during DNA replication catastrophe

Jinal A Patel1, Julie Rageul1, Natalie Lo1

  • 1Department of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, United States.

PubMed

Insights

Targeting cancer cell DNA replication with ATR inhibitors can trigger replication catastrophe, a form of cell death. This strategy diverts therapy-induced senescent cells toward apoptosis, enhancing anti-cancer therapy efficacy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Biology

Background:

  • Cancer therapy often faces limitations due to therapy-induced senescence, which can negatively impact patient outcomes.
  • Exacerbating DNA replication stress in cancer cells is a potential therapeutic strategy.

Purpose of the Study:

  • To investigate a novel therapeutic strategy combining acute replisome dysfunction with Ataxia telangiectasia and Rad3-related (ATR) inhibition.
  • To divert senescent cancer cells towards cell death by inducing replication catastrophe.

Main Methods:

  • Utilized RNA-sequencing to identify p53-responsive genes involved in cell death.
  • Investigated the role of c-Jun N-terminal kinase (JNK) in p53-dependent apoptosis and γH2AX distribution.
  • Elucidated the signaling cascade involving DNA-PKcs, CHK1, MRE11, and PARP1 in replication catastrophe.

Main Results:

  • Identified a distinct set of p53-responsive genes critical for inducing cell death.
  • Demonstrated that JNK activation forms a feed-forward loop with p53 to drive apoptosis and γH2AX pan-nuclear distribution.
  • Established that DNA-PKcs activation initiates replication catastrophe signaling, involving MRE11 and PARP1 in recognizing single-stranded DNA gaps.

Conclusions:

  • The study elucidates the DNA-PKcs/JNK/p53 signaling axis regulating cell fate decisions between senescence and death.
  • Replication catastrophe, driven by specific signaling pathways, represents a targetable vulnerability in cancer therapy.
  • This approach holds potential for limiting senescent cell populations and improving anti-cancer treatment efficacy.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K